Efficacy [qlco]
Safety [hcpp]
mildronate [orch, phsu]
Patients [podg]
Ischaemic [ftcn]
Heart disease [dsyn]
Chronic heart failure [dsyn]
Efficacy [qlco]
Safety [hcpp]
fatty acid oxidation [moft]
Inhibitor [qlco]
mildronate [orch, phsu]
Digoxin [carb, phsu, strd]
Trial, Multicenter [resa]
DOUBLE BLIND [resa]
randomized [resa]
Parallel [qlco]
Group [idcn]
Material [sbst]
Patients [podg]
NYHA Class II [fndg]
Heart failure [dsyn]
ischaemic heart disease [dsyn]
Methods [inpr]
symptoms [ftcn]
Intracardiac [bsoj]
Hemodynamics [ortf]
Tolerance [fndg]
Exercise, Physical [dora]
Study [mnob]
acute [tmco]
drug test [resa]
weeks [tmco]
treatment [ftcn]
mildronate [orch, phsu]
Compared [acty]
placebo [topp]
Course [tmco]
treatment [ftcn]
mildronate [orch, phsu]
mg day [qnco]
increases [ftcn]
Left Ventricle [bpoc]
Contractile [phsf]
Pump [medd]
function [phsf]
Improvement [cnce]
Physical [hlca]
Working [ocac]
Capacity [qnco]
lowering [spco]
NYHA Class [fndg]
Functional [ftcn]
Patients [podg]
mildronate [orch, phsu]
Worsening [qlco]
coronary [bpoc]
Blood flow [orgf]
Digoxin [carb, phsu, strd]
mildronate [orch, phsu]
considered [idcn]
Drug [phsu]
Component [mnob]
Combination Therapy [topp]
Heart failure [dsyn]
Chronic ischaemic heart disease [dsyn]
